Activin signalling and pre-eclampsia: From genetic risk to pre-symptomatic biomarker. Issue 2 (February 2015)

• Record Type: Journal Article
• Authors: Williamson, Rachel D.; O'Keeffe, Gerard W.; Kenny, Louise C.
• Is Part Of: Cytokine. Volume 71:Issue 2(2015)
• Page Start: 360
• Page End: 365
• Publication Date: 2015-02
• Subjects: Cytokines -- Periodicals; 571.844
• DOI: 10.1016/j.cyto.2014.11.017
• Languages: English
• ISSNs: 1043-4666

Abstract

<abstract xml:lang="en" abstract-type="author-highlights" id="ab005"> <title id="st060">Highlights</title> <sec> <p id="sp0005"> <list id="l0005"> <list-item id="o0005"> <label></label> <p id="p0065">Pre-eclampsia is a leading cause of maternal and fetal mortality.</p> </list-item> <list-item id="o0010"> <label></label> <p id="p0070">Activin A serum and placental levels are increased in cases of pre-eclampsia.</p> </list-item> <list-item id="o0015"> <label></label> <p id="p0075">Activin A is therefore being examined as a biomarker for pre-eclampsia.</p> </list-item> </list> </p> </sec> </abstract>